Multiple Sclerosis Treatment Calls for More SolutionsMay 31st 2017
John Dirk Nieland, PhD, associate professor in the Department of Health Science and Technology at Aalborg University in Denmark, discusses his research team's connection between MS and lipid metabolism, the importance of condition-inflicted models, and the encompassing nature of treating MS.
The Responsibility of Strong MS Treatment and Children PatientsMay 27th 2017
Brenda Banwell, MD, FAAP, FRCPC, Children's Hospital of Philadelphia's Neurology Division chief, talks about the cruciality of early diagnosing in pediatric multiple sclerosis patients, and how their best outcome is just being able to live a normal, everyday life.
Degenerative Conditions in Pediatric MS Worsened By Limited Case StudiesMay 26th 2017
Brenda Banwell, MD, FAAP, FRCPC, chief of Childrens Hospital of Philadelphia's Division of Neurology, speaks on new discoveries of pediatric MS at the annual 2017 Consortium of Multiple Sclerosis Centers (CMSC) in New Orleans.
Jeffrey Cohen, MD, Discusses New MS CriteriaMay 26th 2017
The director of experimental therapeutics at the Mellen MS Center at the Cleveland Clinic shared what's shaping the soon-to-be-released update on the most recent 2010 diagnosing criteria at the 2017 Consortium of Multiple Sclerosis Centers.
Stephen Krieger, MD, Talks Ocrelizumab in RRMS and PPMS TreatmentMay 25th 2017
Stephen Krieger, MD, an associate professor at Mount Sinai Hospital, discusses the impact that recently-approved drug ocrelizumab has on the state of multiple sclerosis care, as well as his patient-centered app that depicts the MS condition in a more accurate manner, at the 2017 Consortium of Multiple Sclerosis Centers in New Orleans.
The Broad Spectrum of Marijuana and Alternative Treatment on MSMay 25th 2017
Allen Bowling, MD, PhD, physician associate of the Colorado Neurological Institute, discussed widely-researched benefits of cannabis on MS effects, its shortcomings, and the broad outcomes of alternative treatment.
The Hidden Role of Testosterone in Multiple SclerosisMay 24th 2017
Clyde Markowitz, MD, director of the MS Center at the University of Pennsylvania, discusses how the patterns of male-to-female ratio in MS diagnoses may be linked to hormones, and whether testosterone could be key in bettering treatment.
Interdisciplinary, Patient-centered, Comprehensive Care Necessary for MS TreatmentMay 24th 2017
At CMSC 2017, Aaron Boster, MD, neuroimmunologist for OhioHealth Neurological Clinicians, discussed why he believes there's never been a better time of opportunity for multiple sclerosis patients, and what must be improved in MS diagnosis practice.
Clyde Markowitz From University of Pennsylvania: Moving Multiple Sclerosis Treatment Forward for AllJune 10th 2016
It was not that long ago when doctors would sometimes not discuss the diagnosis of multiple sclerosis with their patients. Now not only is it a condition they can diagnose but treatment is also progressing by leaps and bounds.
Patricia Coyle from Stony Brook University: Moving Care of Progressive Multiple Sclerosis ForwardJune 8th 2016
As the treatment of relapsing remitting multiple sclerosis continues to add new treatment methods patients with progressive forms of the condition are still waiting for their first approved medication to manage their symptoms.
Cheri Roseberry from the University of Arizona College of Nursing: How to Cope with Uncertainty in Multiple SclerosisJune 7th 2016
Acknowledging that uncertainty is a key factor in the care and treatment of multiple sclerosis is part of a solution to a problem, finding the best way to deal with that uncertainty is another issue that must be confronted by patients and doctors alike.
Cheri Roseberry from the University of Arizona College of Nursing: Studying Uncertainty and Other Factors in Multiple Sclerosis CareJune 7th 2016
From the time a patient is diagnosed with multiple sclerosis there are often more questions than answers for extended periods of time. What that means for their care and management of symptoms is the subject of a recent study.
Fred Lublin from Mount Sinai Medical Center: Why Relapses Matter in Multiple Sclerosis CareJune 6th 2016
With a lot of the attention in multiple sclerosis care turning to finding treatments for progressive forms of the disease those who suffer relapses are in some ways being left in the shadows of treatment discoveries and care.
Matt Mandel from Sanofi Genzyme: Taking a Closer Look at a Problem Close to Home with VsMSJune 6th 2016
A recently concluded survey looked at issues most affecting patients with multiple sclerosis that they may not have been willing or able to discuss with health care providers but could help others with the condition in the future.
Rosalind Kalb from the National Multiple Sclerosis Society: The Future of Multiple Sclerosis Care and Patient Support GroupsJune 5th 2016
New medications are constantly being developed and approved for the treatment of multiple sclerosis. How those treatments are used and what the future holds for the disease remains to be seen.
Rosalind Kalb from the National Multiple Sclerosis Society: Gender Plays Role in Multiple Sclerosis Care and TreatmentJune 4th 2016
There are known differences between men and women when it comes to multiple sclerosis and the likelihood of developing the disease. There are also differences in how best to treat patients given their gender.
Rosalind Kalb from the National Multiple Sclerosis Society: Treating the Mental Aspects of Multiple SclerosisJune 4th 2016
In a chronic condition where depression is a known symptom treating the mental condition of a patient can be just as important as the physical aspects especially when suicide prevention is part of the overall care.